gadolinium dtpa has been researched along with imatinib mesylate in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (imatinib mesylate) | Trials (imatinib mesylate) | Recent Studies (post-2010) (imatinib mesylate) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 11,477 | 960 | 5,773 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | imatinib mesylate (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.31 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brasch, RC; Fu, Y; High, WA; Hope, TA; Leboit, PE | 1 |
1 other study(ies) available for gadolinium dtpa and imatinib mesylate
| Article | Year |
|---|---|
Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model.
Topics: Animals; Benzamides; Contrast Media; Gadolinium DTPA; Imatinib Mesylate; Male; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Treatment Outcome | 2013 |